Cargando…

Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy

Interindividual heterogeneity in the disease progression of HIV-1-infected patients receiving long-term antiretroviral therapy suggests that some host-related factors may have limited treatment efficacy. To understand the nature of factors contributing to treatment failure, we performed a retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouyang, Yabo, Yin, Qianqian, Li, Wei, Li, Zhenpeng, Kong, Desheng, Wu, Yanling, Hong, Kunxue, Xing, Hui, Shao, Yiming, Jiang, Shibo, Ying, Tianlei, Ma, Liying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524822/ https://www.ncbi.nlm.nih.gov/pubmed/28740221 http://dx.doi.org/10.1038/s41598-017-05594-5

Ejemplares similares

Identification of the Critical Sites of NNRTI-Resistance in Reverse Transcriptase of HIV-1 CRF_BC Strains
por: Huang, Yang, et al.
Publicado: (2014)

Neutralization sensitivity of HIV-1 subtype B’ clinical isolates from former plasma donors in China
por: OuYang, Yabo, et al.
Publicado: (2013)

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy — China, 2018–2019
por: Li, Miaomiao, et al.
Publicado: (2022)

Characterization of human IgM and IgG repertoires in individuals with chronic HIV-1 infection
por: Tian, Xiaolong, et al.
Publicado: (2022)

One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
por: Li, Wei, et al.
Publicado: (2017)

Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy
por: Hu, Xintao, et al.
Publicado: (2017)

Single-Domain Antibodies As Therapeutics against Human Viral Diseases
por: Wu, Yanling, et al.
Publicado: (2017)

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
por: Brumme, Zabrina L., et al.
Publicado: (2021)

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
por: Brumme, Zabrina L., et al.
Publicado: (2022)

Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment
por: Xing, Hui, et al.
Publicado: (2013)

Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
por: Hu, Yuanyuan, et al.
Publicado: (2021)

Co-receptor usage and prediction of v3 genotyping algorithms in hiv-1 subtype b' from paid blood donors experienced anti-retroviral therapy in chinese central province
por: Qu, Shuiling, et al.
Publicado: (2010)

The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice
por: Liu, Ye, et al.
Publicado: (2013)

Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19
por: He, Lin, et al.
Publicado: (2023)

Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022)

Relationship Between Drug Resistance and Death in HIV-Infected Patients Receiving Antiretroviral Therapy — 7 PLADs, China, 2010−2019
por: Zhang, Tianhao, et al.
Publicado: (2021)

Higher Risk of Mortality and Virologic Failure in HIV-Infected Patients With High Viral Load at Antiretroviral Therapy Initiation: An Observational Cohort Study in Chongqing, China
por: Zhou, Chao, et al.
Publicado: (2022)

Sequential Administration of SARS-CoV-2 Strains-Based Vaccines Effectively Induces Potent Immune Responses against Previously Unexposed Omicron Strain
por: Wang, Qianying, et al.
Publicado: (2023)

Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time
por: Wang, Lijie, et al.
Publicado: (2022)

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
por: Zhang, Dai, et al.
Publicado: (2019)

HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014)

Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF61_BC) Identified among Heterosexuals in China
por: Li, Xingguang, et al.
Publicado: (2013)

HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naïve MSM from 2011 to 2013 in Beijing, China
por: Jiao, Yang, et al.
Publicado: (2014)

Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
por: Liu, Pengtao, et al.
Publicado: (2018)

Metastatic Melanomas Express Inhibitory Low Affinity Fc Gamma Receptor and Escape Humoral Immunity
por: Cohen-Solal, Joel F. G., et al.
Publicado: (2010)

Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?
por: Nicasio, Mancini, et al.
Publicado: (2012)

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2021)

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2021)

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2021)

In-Depth Analysis of Human Neonatal and Adult IgM Antibody Repertoires
por: Hong, Binbin, et al.
Publicado: (2018)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
por: Kan, Wei, et al.
Publicado: (2017)

Construction and Characterization of Highly Infectious Full-Length Molecular Clones of a HIV-1 CRF07_BC Isolate from Xinjiang, China
por: Wang, Zheng, et al.
Publicado: (2013)

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
por: Gaifer, Zied, et al.
Publicado: (2020)

Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
por: Salvi, Sonali, et al.
Publicado: (2022)

Low humoral responses to human cytomegalovirus is associated with immunological treatment failure among HIV infected patients on highly active antiretroviral therapy
por: Mirambo, Mariam Mwinjuma, et al.
Publicado: (2017)

Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study
por: Tang, Zhenzhu, et al.
Publicado: (2017)

Breast abnormalities in adolescents receiving antiretroviral therapy
por: Dunlop, Jackie L., et al.
Publicado: (2019)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
por: Zou, Xueqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cst1riks4onaveud57vl8qlj29